Anton Bennett, Ph.D.
Professor of Pharmacology and of Comparative Medicine; Co-Director, Program in Integrative Cell Signaling and Neurobiology of Metabolism; Director, BBS Minority Affairs

Innovation: Developing a chemical drug design platform to establish rich intellectual property for a first-in-class therapeutic for the treatment of fibrosis which accounts for nearly 45% of all deaths in the developed world. (Development Grant winner)

Elliott Brown, M.D.
Assistant Professor of Radiology and Biomedical Imaging

Innovation: A novel bone marrow aspiration device that limits blood contamination and maximizes stem cell recovery while also increasing the area of bone sampled 45-fold compared to current devices. (Pilot Grant winner)

Michael Giradri, M.D.
Professor, Vice Chair, and Program Director for the Department of Dermatology

Innovation: A multi-functional bioadhesive nanoparticle platform that has the potential to revolutionize the suncare industry. (Pilot Grant winner)

Team: Michael Girardi/W. Mark Saltzman

Andrew Miranker, Ph.D.
Professor of Molecular Biophysics & Biochemistry

Innovation: Advancing a small molecule that is water soluble, non-toxic and crosses the plasma membrane and can work in conjunction with existing diabetes drugs to improve long-term b-cell health. (Pilot Grant winner)

Anna Marie Pyle, Ph.D.
William Edward Gilbert Professor of Molecular, Cellular, and Developmental Biology and Professor of Chemistry; Director, Division of Biological Sciences

Innovation: Developing a proprietary class of molecules to be used as tumor vaccines. (Pilot Grant winner)

W. Mark Saltzman, Ph.D.
Goizueta Foundation Professor of Biomedical Engineering, Chemical & Environmental Engineering & Physiology

Innovation: A multi-functional bioadhesive nanoparticle platform that has the potential to revolutionize the suncare industry. (Pilot Grant winner)

Team: W. Mark Saltzman/Michael Girardi

Alanna Schepartz, Ph.D.
Milton Harris ‘29 Ph.D. Professor of Chemistry & Professor of Molecular, Cellular, and Developmental Biology

Innovation: A robust technology for trafficking diverse protein materials into the cytosol and nucleus with high efficiency and intact form to deliver personalized therapeutics. (Development Grant winner)

Stephen Strittmatter, M.D., Ph.D.
Vincent Coates Professor of Neurology and Professor of Neuroscience; Director, Cellular Neuroscience, Neurodegeneration and Repair; Director, Memory Disorders Clinic; Director, Yale Alzheimer’s Disease Research Center

Innovation: Developing select inhibitors to slow, halt or reverse the course of Alzheimer’s disease. (Development Grant winner)

Andrew Xiao, Ph.D.
Assistant Professor of Genetics

Innovation: Developing therapeutics around a novel epigenetic mechanism aimed at end-stage tumors that are resistant to standard therapies. (Development Grant winner)